Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma.
Rueda A, Rifá J, Quero C, Gómez-Codina J, Murias A, García-Arroyo FR, Sabín P, Llanos M, Herrero J, Lobo F, Delgado JR, Provencio M; Spanish Lymphoma Oncology Group. Rueda A, et al. Among authors: provencio m. Leuk Lymphoma. 2014 Jun;55(6):1413-6. doi: 10.3109/10428194.2013.836601. Epub 2013 Oct 9. Leuk Lymphoma. 2014. PMID: 23964649 No abstract available.
Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications.
Garcia V, Garcia JM, Silva J, Martin P, Peña C, Dominguez G, Diaz R, Herrera M, Maximiano C, Sabin P, Rueda A, Cruz MA, Rodriguez J, Canales MA, Bonilla F, Provencio M. Garcia V, et al. Among authors: provencio m. PLoS One. 2009 Dec 15;4(12):e8173. doi: 10.1371/journal.pone.0008173. PLoS One. 2009. PMID: 20016842 Free PMC article.
Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.
López-Guillermo A, Caballero D, Canales M, Provencio M, Rueda A, Salar A; Spanish Hematology and Hemotherapy Association; Oncological Group for the Treatment of Lymphatic Diseases; Spanish Lymphomas/Autologous Bone Marrow Transplant Group. López-Guillermo A, et al. Among authors: provencio m. Leuk Lymphoma. 2011 Dec;52 Suppl 3:1-14. doi: 10.3109/10428194.2011.629897. Leuk Lymphoma. 2011. PMID: 22149349
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
Guisado-Vasco P, Arranz-Saez R, Canales M, Cánovas A, Garcia-Laraña J, García-Sanz R, Lopez A, López JL, Llanos M, Moraleda JM, Rodriguez J, Rayón C, Sabin P, Salar A, Marín-Niebla A, Morente M, Sánchez-Godoy P, Tomás JF, Muriel A, Abraira V, Piris MA, Garcia JF, Montalban C; Spanish Hodgkin Lymphoma Study Group. Guisado-Vasco P, et al. Leuk Lymphoma. 2012 May;53(5):812-9. doi: 10.3109/10428194.2011.635861. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22185637
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Provencio M, Sabín P, Gómez Codina J, Rueda A, Llanos M, Gumá J, Quero Blanco C, Blasco A, Delgado JR, Cruz MÁ, Aguiar D, García-Arroyo FR, Herrero J, Lavernia J, Martínez Banaclocha N, Morales M, Fuster J, Sáez Cusi Á, Lobo F, Rodríguez Abreu D, de la Cruz L, Antón E, Rodríguez Jiménez A, Arízcun A, Pérez X; GOTEL (Spanish Lymphoma Oncology Group). Provencio M, et al. Clin Transl Oncol. 2012 May;14(5):386-90. doi: 10.1007/s12094-012-0813-3. Clin Transl Oncol. 2012. PMID: 22551546
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M, Cruz Mora MÁ, Gómez-Codina J, Quero Blanco C, Llanos M, García-Arroyo FR, de la Cruz L, Gumá Padró J, Delgado Pérez JR, Sánchez A, Alvarez Cabellos R, Rueda A; Gotel (Spanish Lymphoma Oncology Group). Provencio M, et al. Leuk Lymphoma. 2014 Jan;55(1):51-5. doi: 10.3109/10428194.2013.790544. Epub 2013 Jun 12. Leuk Lymphoma. 2014. PMID: 23573825 Clinical Trial.
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.
Montes-Moreno S, Batlle A, de Villambrosía SG, Sánchez-Espiridión B, Cereceda L, González-Barca E, Purroy N, Pardal E, Martín A, Grande C, Mazorra F, Insunza A, Quero C, Aguiar D, Cruz MA, Rueda A, Llanos M, Codina JG, Arroyo FR, Caballero D, Conde E, López A, Provencio M, Piris M. Montes-Moreno S, et al. Among authors: provencio m. Haematologica. 2014 Aug;99(8):e138-41. doi: 10.3324/haematol.2014.104976. Epub 2014 Apr 24. Haematologica. 2014. PMID: 24763400 Free PMC article. Clinical Trial. No abstract available.
402 results